Adenosine protects against suicidal erythrocyte death

Area of Science:

• Physiology
• Cell Biology
• Biochemistry

Background:

• Eryptosis, or suicidal erythrocyte death, involves cell shrinkage and phosphatidylserine exposure, impairing microcirculation.
• Ischemia triggers adenosine release, typically promoting vasodilation and cytoprotection.
• The influence of adenosine on eryptosis mechanisms remained largely unexplored.

Purpose of the Study:

• To investigate the effect of adenosine on eryptosis.
• To determine if adenosine can prevent or reverse eryptosis.
• To elucidate the potential role of adenosine in maintaining microcirculation during ischemia.

Main Methods:

• Eryptosis markers (phosphatidylserine exposure, cell volume, cytosolic Ca2+ activity) were measured using annexin V binding, forward scatter, and Fluo3 fluorescence.
• Eryptosis was induced by glucose depletion, low chloride solution, okadaic acid (phosphatase inhibitor), and phorbol 12-myristate-13-acetate (PKC activator).
• The effects of varying adenosine concentrations on these induced eryptosis models were analyzed.

Main Results:

• Adenosine partially reversed cell shrinkage and phosphatidylserine exposure induced by glucose depletion and low chloride conditions.
• Adenosine significantly inhibited eryptosis markers induced by okadaic acid and phorbol 12-myristate-13-acetate.
• Protective effects of adenosine were concentration-dependent, with statistical significance observed at specific micromolar concentrations.

Conclusions:

• Adenosine effectively inhibits eryptosis, likely through a mechanism downstream of protein kinase C activation.
• Adenosine's anti-eryptosis effect may contribute to preserving microcirculation in ischemic tissues.
• This study highlights a novel cytoprotective role for adenosine in red blood cells.